Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials

BACKGROUND: Angiotensin receptor blockers (ARBs) and β blockers are widely used in the treatment of Marfan syndrome to try to reduce the rate of progressive aortic root enlargement characteristic of this condition, but their separate and joint effects are uncertain. We aimed to determine these effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Pitcher, Alex, Spata, Enti, Emberson, Jonathan, Davies, Kelly, Halls, Heather, Holland, Lisa, Wilson, Kate, Reith, Christina, Child, Anne H, Clayton, Tim, Dodd, Matthew, Flather, Marcus, Jin, Xu Yu, Sandor, George, Groenink, Maarten, Mulder, Barbara, De Backer, Julie, Evangelista, Arturo, Forteza, Alberto, Teixido-Turà, Gisela, Boileau, Catherine, Jondeau, Guillaume, Milleron, Olivier, Lacro, Ronald V, Sleeper, Lynn A, Chiu, Hsin-Hui, Wu, Mei-Hwan, Neubauer, Stefan, Watkins, Hugh, Dietz, Hal, Baigent, Colin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613630/
https://www.ncbi.nlm.nih.gov/pubmed/36049495
http://dx.doi.org/10.1016/S0140-6736(22)01534-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613630/
https://www.ncbi.nlm.nih.gov/pubmed/36049495
http://dx.doi.org/10.1016/S0140-6736(22)01534-3

Ejemplares similares